Organisation profile

Organisation profile

Our mission is to improve patient care through the development of:

- Biomarkers for prognosis, prediction and markers of response;
- Biologically determined targeted therapies.

The Centre for Cancer Research & Cell Biology (CCRCB) at Queen's University Belfast is a cross-Faculty, interdisciplinary research centre with over 300 clinical and basic researchers from across the world and is committed to the highest quality of research excellence. To achieve our mission we are pursuing the highest quality clinical and basic science research programmes. The hallmark of our research programme is a close, collaborative interaction between clinical and laboratory research experts that ultimately enhances the quality and scope of our integrated basic and clinical research programmes in cancer as well as other diseases.

Fingerprint Dive into the research topics where Centre for Cancer Research and Cell Biology is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Neoplasms Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Genes Medicine & Life Sciences
Mutation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1986 2019

1 Citation (Scopus)

Acute and chronic hypoxia differentially predispose lungs for metastases

Reiterer, M., Colaço, R., Emrouznejad, P., Jensen, A., Rundqvist, H., Johnson, R. S. & Branco, C., 15 Jul 2019, In : Scientific Reports. 9, 15 p., 10246.

Research output: Contribution to journalArticle

Open Access
Endothelial cells
Neoplasm Metastasis
Endothelial Cells
8 Citations (Scopus)

AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine

Lux, F., Tran, V. L., Thomas, E., Dufort, S., Rossetti, F., Martini, M., Truillet, C., Doussineau, T., Bort, G., Denat, F., Boschetti, F., Angelovski, G., Detappe, A., Crémillieux, Y., Mignet, N., Doan, B-T., Larrat, B., Meriaux, S., Barbier, E., Roux, S. & 28 othersFries, P., Müller, A., Abadjian, M-C., Anderson, C., Canet-Soulas, E., Bouziotis, P., Barberi-Heyob, M., Frochot, C., Verry, C., Balosso, J., Evans, M., Sidi-Boumedine, J., Janier, M., Butterworth, K., McMahon, S., Prise, K., Aloy, M-T., Ardail, D., Rodriguez-Lafrasse, C., Porcel, E., Lacombe, S., Berbeco, R., Allouch, A., Perfettini, J-L., Chargari, C., Deutsch, E., Le Duc, G. & Tillement, O., 01 Jan 2019, In : British Journal of Radiology. 92, 1093, 19 p., 20180365.

Research output: Contribution to journalArticle

Open Access
Clinical Medicine
Radiation-Sensitizing Agents

Alginate/Chitosan Particle-Based Drug Delivery Systems for Pulmonary Applications

Hill, M., Twigg, M., Sheridan, E. A., Hardy, J. G., Elborn, J. S., Taggart, C. C., Scott, C. J. & Migaud, M. E., 02 Aug 2019, In : Pharmaceutics. 11, 8, 12 p., 379.

Research output: Contribution to journalArticle

Open Access
Drug Delivery Systems
Cystic Fibrosis


2007 The Liebig Lectureship of the German Chemical Society (GDCh)

Karl Hale (Recipient), 2007

Prize: Prize (including medals and awards)

Organic Chemistry
Pharmaceutical Chemistry

2010 Japan Society for the Promotion of Science Invitation Research Fellowship

Karl Hale (Recipient), 2010

Prize: Prize (including medals and awards)

Science Council

Activities 1996 2100

Birgitte Henrikson

Suneil Jain (Host)
22 Sep 2100

Activity: Hosting a visitor typesHosting of external, non-academic visitor

MSc (Research)

Jaine Blayney (Examiner)
01 Jan 2019 → …

Activity: Examination typesPhD external examination

International Journal of Molecular Sciences (Journal)

Emma Evergren Mills (Peer reviewer)
2019 → …

Activity: Publication peer-review and editorial work typesPublication peer-review

Press / Media

CT-based radiomics reveals prostate cancer risk

Sarah Osman


1 media contribution

Press/Media: Other

BBC NI- Oesophageal Cancer Interview

Richard Turkington


1 item of media coverage

Press/Media: Expert Comment

UTV- Oesophageal Cancer Interview

Richard Turkington


1 item of media coverage

Press/Media: Expert Comment


Development and Commercialization of a Technology Platform to Enable Biomarker Discovery and Validation

Richard Kennedy (Participant), Paul Harkin (Participant), Patrick Johnston (Participant), Alison Hosey (Participant), Julia Miskelly (Participant), Margaret Murray (Participant), Jennifer Quinn (Participant), Colin James (Participant), Jude Mulligan (Participant), Peter Daly (Participant), Paul Mullan (Participant), Julie Mussen (Participant), Ultan McDermott (Participant), Richard Wilson (Participant), Daniel Longley (Participant)

Impact: Health Impact, Quality of Life Impact

Identifying Patients with Rare Forms of Erythrocytosis

Mary Frances McMullin (Participant), Terence Lappin (Participant), Anne Hughes (Participant)

Impact: Health Impact, Quality of Life Impact

Successful Commercial Exploitation of Digital Pathology for Cancer Education, Biomarker Discovery and Clinical Diagnosis

Peter Hamilton (Participant), James Diamond (Participant), Yinhai Wang (Participant), Ching-Wei Wang (Participant), Paul Kelly (Participant), Jacqueline James (Participant), Dean Fennell (Participant)

Impact: Health Impact, Quality of Life Impact